WASHINGTON, July 27 (Reuters) - A U.S. Food and Drug Administration advisory panel on Tuesday:
* Said Medtronic's Amplify device is safe for spinal fusion
* FDA panel voted 9-4 that Medtronic showed reasonable assurance of Amplify's
safety, one panelist abstained
* Said Medtronic's Amplify device is effective for spinal fusion
* Voted 10-3 that Medtronic showed reasonable assurance of Amplify's
effectiveness, one abstained
* Narrowly backed Medtronic's Amplify spine device
* Voted 6-5 that benefits of Medtronic's Amplify spine device
outweigh risks, 3 panelists abstained
(Company news desk in Washington; +1 202 898 8400, washington.newsroom@thomsonreuters.com) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Said Medtronic's Amplify device is safe for spinal fusion
* FDA panel voted 9-4 that Medtronic showed reasonable assurance of Amplify's
safety, one panelist abstained
* Said Medtronic's Amplify device is effective for spinal fusion
* Voted 10-3 that Medtronic showed reasonable assurance of Amplify's
effectiveness, one abstained
* Narrowly backed Medtronic's Amplify spine device
* Voted 6-5 that benefits of Medtronic's Amplify spine device
outweigh risks, 3 panelists abstained
(Company news desk in Washington; +1 202 898 8400, washington.newsroom@thomsonreuters.com) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.